Basic Information
ID: ALA4417627
Title: Dab2 inhibitors for the prevention and treatment of cystic fibrosis
Patent ID: US-20170304392-A1
Associated Items: Associated Bioactivities Associated Assays Associated Compounds Associated Targets
ID: ALA4417627
Title: Dab2 inhibitors for the prevention and treatment of cystic fibrosis
Patent ID: US-20170304392-A1